Sang, Y.B.; Lee, C.; Kim, S.-G.; Lee, B.; Kang, B.; Kim, C.; Chon, H.J.
Impact of Coronavirus Disease 2019 on Unresectable Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab. J. Clin. Med. 2024, 13, 1335.
https://doi.org/10.3390/jcm13051335
AMA Style
Sang YB, Lee C, Kim S-G, Lee B, Kang B, Kim C, Chon HJ.
Impact of Coronavirus Disease 2019 on Unresectable Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab. Journal of Clinical Medicine. 2024; 13(5):1335.
https://doi.org/10.3390/jcm13051335
Chicago/Turabian Style
Sang, Yun Beom, Chaeryoung Lee, Seul-Gi Kim, Boyoung Lee, Beodeul Kang, Chan Kim, and Hong Jae Chon.
2024. "Impact of Coronavirus Disease 2019 on Unresectable Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab" Journal of Clinical Medicine 13, no. 5: 1335.
https://doi.org/10.3390/jcm13051335
APA Style
Sang, Y. B., Lee, C., Kim, S.-G., Lee, B., Kang, B., Kim, C., & Chon, H. J.
(2024). Impact of Coronavirus Disease 2019 on Unresectable Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab. Journal of Clinical Medicine, 13(5), 1335.
https://doi.org/10.3390/jcm13051335